Celldex Therapeutics Stock Volatility
| CLDX Stock | USD 38.85 0.87 2.29% |
We consider Celldex Therapeutics very steady. Celldex Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0321, which signifies that the company had a 0.0321% return per unit of risk over the last 3 months. We have found thirty technical indicators for Celldex Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Celldex Therapeutics' Mean Deviation of 2.5, downside deviation of 2.65, and Risk Adjusted Performance of 0.0162 to double-check if the risk estimate we provide is consistent with the expected return of 0.14%. Key indicators related to Celldex Therapeutics' volatility include:
720 Days Market Risk | Chance Of Distress | 720 Days Economic Sensitivity |
Celldex Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Celldex daily returns, and it is calculated using variance and standard deviation. We also use Celldex's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Celldex Therapeutics volatility.
Celldex |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Celldex Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Celldex Therapeutics at lower prices. For example, an investor can purchase Celldex stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Celldex Therapeutics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Celldex Therapeutics Market Sensitivity And Downside Risk
Celldex Therapeutics' beta coefficient measures the volatility of Celldex stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Celldex stock's returns against your selected market. In other words, Celldex Therapeutics's beta of 1.07 provides an investor with an approximation of how much risk Celldex Therapeutics stock can potentially add to one of your existing portfolios. Celldex Therapeutics currently demonstrates below-average downside deviation. It has Information Ratio of -0.01 and Jensen Alpha of -0.04. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Celldex Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Celldex Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Celldex Therapeutics Demand TrendCheck current 90 days Celldex Therapeutics correlation with market (NYSE Composite)Celldex Beta |
Celldex standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 4.44 |
It is essential to understand the difference between upside risk (as represented by Celldex Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Celldex Therapeutics' daily returns or price. Since the actual investment returns on holding a position in celldex stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Celldex Therapeutics.
Using Celldex Put Option to Manage Risk
Put options written on Celldex Therapeutics grant holders of the option the right to sell a specified amount of Celldex Therapeutics at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Celldex Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Celldex Therapeutics' position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Celldex Therapeutics will be realized, the loss incurred will be offset by the profits made with the option trade.
Celldex Therapeutics' PUT expiring on 2024-05-17
Profit |
| Celldex Therapeutics Price At Expiration |
Current Celldex Therapeutics Insurance Chain
| Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Put | 2024-05-17 PUT at $50.0 | -0.8364 | 0.0279 | 4 | 2024-05-17 | 10.6 - 12.9 | 6.3 | View |
Put | 2024-05-17 PUT at $45.0 | -0.9937 | 3.218 | 601 | 2024-05-17 | 5.5 - 6.8 | 1.8 | View |
Put | 2024-05-17 PUT at $40.0 | -0.5576 | 0.0797 | 135 | 2024-05-17 | 2.35 - 2.8 | 3.75 | View |
Put | 2024-05-17 PUT at $35.0 | -0.1973 | 0.0522 | 79 | 2024-05-17 | 0.45 - 0.8 | 1.2 | View |
Celldex Therapeutics Stock Volatility Analysis
Volatility refers to the frequency at which Celldex Therapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Celldex Therapeutics' price changes. Investors will then calculate the volatility of Celldex Therapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Celldex Therapeutics' volatility:
Historical Volatility
This type of stock volatility measures Celldex Therapeutics' fluctuations based on previous trends. It's commonly used to predict Celldex Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Celldex Therapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Celldex Therapeutics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Celldex Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Celldex Therapeutics Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 1.0653 suggesting Celldex Therapeutics market returns are sensitive to returns on the market. As the market goes up or down, Celldex Therapeutics is expected to follow.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Celldex Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Celldex Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Celldex stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Celldex Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Predicted Return Density |
| Returns |
What Drives a Celldex Therapeutics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Celldex Therapeutics Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Celldex Therapeutics is 3112.2. The daily returns are distributed with a variance of 19.75 and standard deviation of 4.44. The mean deviation of Celldex Therapeutics is currently at 2.53. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.62
α | Alpha over NYSE Composite | -0.04 | |
β | Beta against NYSE Composite | 1.07 | |
σ | Overall volatility | 4.44 | |
Ir | Information ratio | -0.008 |
Celldex Therapeutics Stock Return Volatility
Celldex Therapeutics historical daily return volatility represents how much of Celldex Therapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 4.4441% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.637% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Celldex Therapeutics Volatility
Volatility is a rate at which the price of Celldex Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Celldex Therapeutics may increase or decrease. In other words, similar to Celldex's beta indicator, it measures the risk of Celldex Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Celldex Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 16.9 B | 11 B | |
| Market Cap | 1.7 B | 1.8 B |
Celldex Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Celldex Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Celldex Therapeutics' price varies over time.
3 ways to utilize Celldex Therapeutics' volatility to invest better
Higher Celldex Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Celldex Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Celldex Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Celldex Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Celldex Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Celldex Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Celldex Therapeutics Investment Opportunity
Celldex Therapeutics has a volatility of 4.44 and is 6.94 times more volatile than NYSE Composite. 39 percent of all equities and portfolios are less risky than Celldex Therapeutics. You can use Celldex Therapeutics to enhance the returns of your portfolios. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Celldex Therapeutics to be traded at $46.62 in 90 days.Average diversification
The correlation between Celldex Therapeutics and NYA is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Celldex Therapeutics and NYA in the same portfolio, assuming nothing else is changed.
Celldex Therapeutics Additional Risk Indicators
The analysis of Celldex Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Celldex Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Celldex Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0162 | |||
| Market Risk Adjusted Performance | 0.0515 | |||
| Mean Deviation | 2.5 | |||
| Semi Deviation | 2.57 | |||
| Downside Deviation | 2.65 | |||
| Coefficient Of Variation | 8075.16 | |||
| Standard Deviation | 4.38 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Celldex Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Celldex Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Celldex Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Celldex Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Celldex Therapeutics.
When determining whether Celldex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Celldex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Celldex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Celldex Therapeutics Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celldex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Celldex Stock please use our How to Invest in Celldex Therapeutics guide.Note that the Celldex Therapeutics information on this page should be used as a complementary analysis to other Celldex Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Celldex Stock analysis
When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is Celldex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Celldex Therapeutics. If investors know Celldex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Celldex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.92) | Revenue Per Share 0.142 | Quarterly Revenue Growth 1.561 | Return On Assets (0.22) | Return On Equity (0.37) |
The market value of Celldex Therapeutics is measured differently than its book value, which is the value of Celldex that is recorded on the company's balance sheet. Investors also form their own opinion of Celldex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Celldex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Celldex Therapeutics' market value can be influenced by many factors that don't directly affect Celldex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Celldex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Celldex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Celldex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.